You Are Here: Home » IRMI » Reimbursement Strategies for Stem Cell and Regenerative Medicine Therapies

Reimbursement Strategies for Stem Cell and Regenerative Medicine Therapies

Reimbursement Strategies for Stem Cell and Regenerative Medicine Therapies

Reimbursement Strategies Webinar

Planning Your Payment Strategy in Early Product Development

Webinar Information:

The webinar was held on June 20, 2013.  Please click here to watch a recording of the webinar, including the question and answer section in the last 10 minutes of the presentation.

Please click here to download the slides from the webinar.

WEBINAR AGENDA

EXPERT SPEAKERS:

  • Michael Werner, J.D., Executive Director, Alliance for Regenerative Medicine; Partner at Holland & Knight, LLP
  • Randy Fenninger, J.D., Principal, Creek Crossing Advisors

TOPICS:

  • Primer on coding, coverage and payment rules and processes that determine whether a regenerative medicine product will be reimbursed
  • Understanding why you should develop and adopt a reimbursement strategy early in product development
  • Understand how your reimbursement strategy and regulatory strategy coincide
  • Understand how new reimbursement rules and payment models such as ACOs, payment bundling, and comparative effectiveness analysis will affect regenerative medicine technologies and develop strategies to succeed.
  • Questions and Answers

Leave a Comment

Current month ye@r day *

Scroll to top